Report Highlights
- The global market for human microbiome-based drugs and diagnostics was valued at $315.2 million in 2024 and is expected to reach $1.2 billion by the end of 2030, at a CAGR of 25.6% from 2025 to 2030.
- The global market for molecular diagnostics was valued at $20.3 billion in 2024 and is expected to reach $42.6 billion by the end of 2030, at a CAGR of 13.1% from 2025 to 2030.
- The global market for noninvasive cancer diagnostics was valued at $112.8 billion in 2024 and is projected to reach $165.2 billion by the end of 2030, at a CAGR of 6.6% from 2025 to 2030.
Report Scope
The diagnostics industry has grown despite the challenging economic conditions in recent years. The industry draws much attention and scrutiny from the public and government, and is currently undergoing many changes due to increased focus on regulations. These changes can be seen across many countries. The U.S., the largest diagnostics market, is leading the trend with changes intended to make healthcare more affordable. Opportunities for the diagnostics industry are manifold, with the appearance of new markets located mainly in emerging economies with varying needs.
Increasing healthcare expenditures and the growth of emerging economies have increased the demand for technologically better diagnostic devices, kits, reagents, and other accessories. Additionally, the introduction of more stringent regulations, specifically in the developed markets of the U.S. and Europe, has forced diagnostics manufacturers to launch advanced products that include new materials, a focus on in-depth indications, and the ability to produce additional new data.
Some of the major driving factors in the market are the increasing prevalence of chronic and infectious diseases, technological advances in diagnostics, increasing investments in AI in the diagnostics market, increased applications in non-oncology areas, and growing adoption of personalized medicine.
Furthermore, technically sophisticated diagnostics are needed for clinical research, as the market is highly competitive, and companies must continuously reinvent their product portfolios to enter new markets and place themselves as key participants in the healthcare system. There is a shift toward a value-based healthcare market where price and purchase decisions are based on outcomes. This has further led to increased scrutiny of device technology, and consequently, the degree of competition has risen. Some of the major firms in the diagnostics market include Abbott, Medtronic, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Agilent Technologies Inc., QIAGEN, Danaher Corp., Sysmex, Thermo Fisher Scientific Inc., BD, and others.
The diagnostics industry is a multi-billion-dollar market with an outlook for continued growth in the coming years. Hospital care is growing, and the diagnostics industry is being looked at to provide low-cost technology for home healthcare. Now, the industry seeks healthcare diagnostic devices, kits, and reagents that individuals with unskilled healthcare experience can use. The need for modern technology, equipment, and devices can be leveraged through diagnostic equipment as manufacturers seek to create better-quality healthcare solutions.
The above reasons are compelling enough to analyze and research the diagnostics market, as the market has tremendous growth potential.
It includes highlights from these reports published in 2024:
- MDS051B Tissue Diagnostics: Technologies and Global Markets
- HLC300A Global Colorectal Cancer Screening and Diagnostics Market
- MDS046B Oncology Diagnostics: Global Markets
- BIO150E Liquid Biopsy Research Tools, Services, and Diagnostics
- BIO151B Human Microbiome-based Drugs and Diagnostics
- BIO063F Molecular Diagnostics: Technologies and Global Markets
- HLC186D In Vitro Diagnostics: Technologies and Global Markets
- PHM026D Global Markets for Allergy Diagnostics and Treatments
- HLC197B Noninvasive Cancer Diagnostics: Technologies and Global Markets
- HLC029G Global Markets for Diabetes Therapeutics and Diagnostics
After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.
Related Reports
2025 Medical Devices Research Review
Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.
Immunotherapy Drugs: Global Markets
The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2025 to 2030.
Fusion Proteins: Global Market
The global market for fusion proteins is expected to grow from $36.3 billion in 2025 to reach $64.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2030.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
2025 DNA and RNA Synthesis Research Review
Discover the 2025 DNA and RNA Synthesis Research Review from BCC Research with insights into market developments, innovation trends and strategic opportunities.
2025 Diagnostics Research Review
Discover the 2025 Diagnostics Research Review from BCC Research with insights into diagnostics market trends, emerging technologies and strategic opportunities.
2025 Protein Synthesis Research Review
Explore BCC Research’s 2025 Protein Synthesis Research Review covering market trends, synthesis technologies, research developments and growth opportunities across the sector.
Biometrics as a Service in Medical Devices: Global Markets
The global biometrics as a service in the medical devices market study covers market size, dynamics, technologies, industry structure, and growth trends, segmented by product, modality, application, and region. It provides 2024 revenue data and forecasts for 2025–2030, with segments including fingerprint, voice, iris, and facial, and applications such as patient registries and remote monitoring. The report also includes regional analysis and a competitive landscape with profiles of key market players.
Global DNA Read, Write, and Edit Market
The global market for DNA read, write, and edit was valued at $25.9 billion in 2025 and is estimated to reach $67.7 billion by 2030, at a compound annual growth rate (CAGR) of 21.2% from 2025 through 2030.
Top Trending Reports
Global Markets for Diabetes Therapeutics and Diagnostics
The global market for diabetes therapeutics and diagnostics is estimated to grow from $134.9 billion in 2025 to reach $241.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% from 2025 through 2030.
Stem Cell and Regenerative Therapy: Global Markets
The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.
Power Infrastructure for Data Centers: Global Markets
This report provides a comprehensive analysis of global power infrastructure for data centers market, segmented by power infrastructure component, data center type, and end-use. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps and devices is expected to grow from $9.7 billion in 2025 and is projected to reach $14.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2025 to 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Report Highlights
- The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
- The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 and is projected to reach $15.4 billion by 2028, at a CAGR of 15.2% from 2023 through 2028.
- The global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3 billion by the end of 2029, at a CAGR of 7.6% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More